Eisai Co Ltd

» Auto updated continuously

Display limited to 'Eisai Co Ltd' in document titles and meta descriptions. Display In Whole Documents or use the calendar above to adjust the date setting.

 2018-07-31 10:48 

Markets Insider

Merck : FDA Grants Breakthrough Therapy Designation For LENVIMA With KEYTRUDA...

(RTTNews) - Eisai Co., Ltd. and Merck & Co Inc. (MRK) said that the U.S. Food and Drug Administration granted Breakthrough Therapy designation for LENVIMA or lenvatinib, the orally available kinase inhibitor discovered by Eisai, in combination with Merck&...

 2018-07-26 06:41 

Reuters

[ Health ]

Investors turn wary on Biogen/Eisai Alzheimer's drug results...

Shares of Eisai Co Ltd plunged as much as 21 percent after the results of its experimental Alzheimer's drug being developed with partner Biogen Inc failed to enthuse investors....

 2018-07-26 06:41 

Reuters

[ UK ]

Investors turn wary on Biogen/Eisai Alzheimer's drug results...

Shares of Eisai Co Ltd plunged as much as 21 percent after the results of its experimental Alzheimer's drug being developed with partner Biogen Inc failed to enthuse investors....

 2018-07-26 01:49 

Reuters

[ UK ]

Biogen/Eisai Alzheimer's drug cuts cognitive decline 30 percent: study...

Biogen Inc and partner Eisai Co Ltd said patients with early-stage Alzheimer's disease treated with their experimental drug BAN2401 experienced 30 percent less cognitive decline than those who got a placebo in a highly anticipated mid-stage trial....

 2018-07-25 22:24 

Reuters

[ World ]

Biogen/Eisai Alzheimer's drug cuts cognitive decline 30 percent: study...

Biogen Inc and partner Eisai Co Ltd said patients with early-stage Alzheimer's disease treated with their experimental drug BAN2401 experienced 30 percent less cognitive decline than those who got a placebo in a highly anticipated midstage trial....

 2018-07-25 20:56 

Channel NewsAsia

Biogen/Eisai Alzheimer's drug cut cognitive decline by 30 percent: study...

CHICAGO: Biogen Inc and partner Eisai Co Ltd said patients with early-stage Alzheimer's disease treated with their experimental drug BAN2401 ......

 2018-07-25 20:56 

Channel NewsAsia

Biogen/Eisai Alzheimer's drug cut cognitive decline by 30%: study...

CHICAGO: Biogen Inc and partner Eisai Co Ltd said patients with early-stage Alzheimer's disease treated with their experimental drug BAN2401 ......

 2018-07-25 20:51 

Reuters

[ World ]

Biogen/Eisai Alzheimer's drug cut cognitive decline by 30 percent: study...

Biogen Inc and partner Eisai Co Ltd said patients with early-stage Alzheimer's disease treated with their experimental drug BAN2401 experienced 30 percent less cognitive decline than patients who got a placebo in a highly anticipated midstage trial....

 2018-07-25 20:30 

Reuters

[ World ]

Biogen/Eisai Alzheimer's drug cut cognitive decline by 30 pct -study...

Biogen Inc and partner Eisai Co Ltd said patients with early-stage Alzheimer's disease treated with their experimental drug BAN2401 experienced 30 percent less cognitive decline than patients who got a placebo in a highly anticipated midstage trial....

 2018-07-25 20:25 

Markets Insider

Eisai And Biogen Announce Detailed Results Of Phase II Clinical Study Of BAN2401 In Early Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018...

TOKYO and CAMBRIDGE, Mass., July 25, 2018 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB) (Headquarters:...

 2018-07-24 09:44 

Reuters

[ UK ]

Eisai-Biogen to advance Alzheimer's drug, provide fresh hope...

Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer's disease drug, BAN2401, and are working with regulators to design the next studies and gain expedited review as a breakthrough therapy....

 2018-07-24 05:13 

Reuters

[ Health ]

Eisai-Biogen to advance Alzheimer's drug, provide fresh hope...

Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer's disease drug, BAN2401, and are working with regulators to design the next studies and gain expedited review as a breakthrough therapy....

 2018-07-24 05:05 

Channel NewsAsia

Eisai/Biogen to advance Alzheimer's drug, provide fresh hope...

REUTERS: Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer's disease drug, BAN2401, and are working ......

Page 1 of 1

  • Need an account?  
    or